Lv1
90 积分 2023-09-08 加入
MA17.04 Patient-Reported Outcomes (PROs) With Consolidation Durvalumab Versus Placebo Following cCRT in Limited-Stage SCLC: ADRIATIC
9小时前
求助中
Persistence and/or Senescence: Not So Lasting at Last?
1个月前
已完结
Neoadjuvant immunochemoradiotherapy versus chemoradiotherapy in esophageal cancer: a systematic review and meta-analysis of reconstructed individual patient data
2个月前
已完结
Chemotherapy-Based Combination Regimens for Advanced EGFR-Mutant NSCLC After EGFR-TKI Failure: A Network Meta-Analysis
2个月前
已完结
Neoadjuvant immunochemoradiotherapy versus chemoradiotherapy in esophageal cancer: a systematic review and meta-analysis of reconstructed individual patient data
2个月前
已完结
Circulating tumor DNA Clearance as a Predictive Biomarker of Pathologic Complete Response in Patients with Solid Tumors Treated with Neoadjuvant Immune-Checkpoint Inhibitors: a Systematic Review and Meta-Analysis
2个月前
已完结
Adverse events of immunotherapy in non-small cell lung cancer: A systematic review and network meta-analysis
2个月前
已完结
Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: a systematic review and meta-analysis
2个月前
已完结
Safety and efficacy of antibody-drug conjugates plus immunotherapy in solid tumours: A systematic review and meta-analysis
2个月前
已完结
Chemoimmunotherapy combined with consolidative thoracic radiotherapy for extensive-stage small cell lung cancer: A systematic review and meta-analysis
2个月前
已完结
皖公网安备34019202002308
